[{"AccountsPayableCurrent_0_Q2_USD":11263000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":167170000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1786000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":22218000.0,"IncomeTaxesReceivable_0_Q2_USD":22218000.0,"OperatingLeaseExpense_2_Q2_USD":1900000.0,"OperatingLeaseExpense_1_Q2_USD":1000000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1058606000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":33243931.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":33265778.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":55400000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":55400000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":94.68,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":448700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":973999.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":171917.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":33.31,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2240699.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":278200000.0,"OtherAssetsNoncurrent_0_Q2_USD":7670000.0,"NonoperatingIncomeExpense_1_Q2_USD":-16990000.0,"NonoperatingIncomeExpense_2_Q2_USD":-20804000.0,"LongTermDebtNoncurrent_0_Q2_USD":0.0,"EarningsPerShareBasic_2_Q2_USD":-3.51,"EarningsPerShareBasic_1_Q2_USD":-2.03,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1448000.0,"EarningsPerShareDiluted_1_Q2_USD":-2.03,"EarningsPerShareDiluted_2_Q2_USD":-3.51,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":3073000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.096,"OperatingLeaseRightOfUseAsset_0_Q2_USD":7653000.0,"OperatingLeasePayments_2_Q2_USD":1900000.0,"OperatingLeasePayments_1_Q2_USD":1000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":5212000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3452000.0,"OperatingLeaseLiability_0_Q2_USD":8664000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1041000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2063000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4142000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3500000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":203.19,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":9705000.0,"InvestmentIncomeNonoperating_1_Q2_USD":501000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-4247000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":2363000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4688000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":14796000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":34104000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":6940000.0,"AmortizationOfFinancingCosts_2_Q2_USD":4163000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":34104000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":14796000.0,"OtherLiabilitiesCurrent_0_Q2_USD":14545000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2338000.0,"InvestmentIncomeNonoperating_2_Q2_USD":2555000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":37.51,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":72.27,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4793680.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":384000.0,"NetIncomeLoss_1_Q2_USD":-67581000.0,"NetIncomeLoss_2_Q2_USD":-116520000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-237107000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-384000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":183586000.0,"LiabilitiesNoncurrent_0_Q2_USD":373592000.0,"LiabilitiesCurrent_0_Q2_USD":47185000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":652404000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1815000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":9355000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-22243000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7830000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-3000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-67584000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":37387000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16600000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.51,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-2.03,"Depreciation_2_Q2_USD":562000.0,"Depreciation_1_Q2_USD":284000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-53905000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":610419000.0,"AssetsCurrent_0_Q2_USD":640467000.0,"Assets_0_Q2_USD":652404000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4793680.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-138763000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":4426000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":55399000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":4267000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-11183000.0,"GainsLossesOnExtinguishmentOfDebt_0_Q2_USD":-11200000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":-11183000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.16,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":33243931.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":33265778.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":1786000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":365000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":47351.0,"ProfitLoss_2_Q2_USD":-116520000.0,"ShareBasedCompensation_2_Q2_USD":34104000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":36783000.0,"OperatingExpenses_2_Q2_USD":122385000.0,"OperatingExpenses_1_Q2_USD":53667000.0,"InterestPaidNet_2_Q2_USD":8021000.0,"InterestExpense_2_Q2_USD":11512000.0,"InterestExpense_1_Q2_USD":5644000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":16689000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":33243931.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":33265778.0,"StockholdersEquity_0_Q2_USD":231627000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-827013000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":84436000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]